Across the world's largest cities, WRI estimates the longest heatwave each year could last 16.3 days on average under a 1.5°C scenario, but 24.5 days at 3°C
world13 hours ago
Mpox vaccines have been administered in Africa for the first time, with several hundred high-risk individuals vaccinated in Rwanda, the African Union's disease control centre said Thursday.
The first 300 doses were administered on Tuesday near the border with the Democratic Republic of Congo, a spokesperson for the AU's Centres for Disease Control and Prevention (Africa CDC) told AFP.
The DRC has been the worst-affected country, with nearly 22,000 cases and more than 700 deaths linked to the virus between January and August.
On a call with reporters, Africa CDC director general Jean Kaseya said vaccinations would start in the DRC in "the first week of October".
Mpox, previously known as monkeypox, is caused by a virus transmitted to humans by infected animals that can also be passed from human to human through close physical contact.
Deadly in some cases, it causes fever, muscular aches and large boil-like lesions on the skin.
The World Health Organisation last week prequalified an mpox vaccine, MVA-BN, for the first time, paving the way for the United Nations and other international agencies to procure them.
The Africa CDC says there has been a total of 29,152 cases and 738 deaths across 15 countries on the continent.
"Mpox is not under control," said Kaseya.
According to the WHO prequalification, the vaccine can be administered to people over the age of 18 as a two-dose injection given four weeks apart.
With most mpox cases and deaths in the DRC in children, the WHO stressed the vaccine could be used "off-label" in infants, children and adolescents, as well as in pregnant and immunocompromised people.
"This means vaccine use is recommended in outbreak settings where the benefits of vaccination outweigh the potential risks," the WHO said in a recent briefing.
The agency also recommends single-dose use in outbreak settings where supplies of the vaccine are constrained. But more data is needed on vaccine safety and effectiveness in such circumstances, it stressed.
It said the currently available data showed that a single dose of the MVA-BN vaccine given before exposure had an estimated 76-per cent effectiveness in protecting against mpox, while two doses were estimated to be 82 per cent effective.
ALSO READ:
Across the world's largest cities, WRI estimates the longest heatwave each year could last 16.3 days on average under a 1.5°C scenario, but 24.5 days at 3°C
world13 hours ago
The move aims at taming record immigration levels that pushed country's population past 41 million earlier this year
world14 hours ago
Wickremesinghe, Premadasa, and Dissanayake are the main contenders for the post
world14 hours ago
His visit to Cairo aimed to salvage stalled negotiations mediated by Egypt, Qatar and the United States to end the conflict
world1 day ago
Hundreds of pagers belonging to the armed group exploded in Lebanon on Tuesday, killed 12 people, including two children, and wounded up to 2,800 others
world1 day ago
Over a week ago, India had reported its first case in a man who had arrived from western Africa in Delhi
world1 day ago
Government faces challenge of accelerating IMF reforms
world1 day ago
Thailand reported three more deaths on Wednesday, taking the toll in the kingdom to 18, with a total of 537 fatalities now confirmed across the region
world1 day ago